Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor
- PMID: 15308689
- DOI: 10.1210/me.2004-0245
Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor
Abstract
We have used chromatin immunoprecipitation (ChIP) assay to follow transcription factor loading and monitor changes in covalent histone modifications associated with the prostate-specific antigen and kallikrein (KLK2) genes in response to androgen and antiandrogen in LNCaP cells. The dynamics of testosterone (T)-induced loading of androgen receptor (AR) onto the proximal promoters of the genes differed significantly from that onto the distal enhancers. Significantly more holo-AR was loaded onto the enhancers than the promoters, but the receptor's residence time was more transient on the enhancers. Even though holo-AR recruited some RNA polymerase II (Pol II) onto the enhancers, the principal Pol II transcription complex was assembled on the promoters. The pure antiandrogen bicalutamide (CDX) complexed to AR elicited occupancy of the prostate-specific antigen promoter, but not that of the enhancer, whereas the partial antagonists cyproterone acetate (CPA) and mifepristone (RU486) were capable of promoting AR loading also onto the enhancer. In contrast to the CDX-occupied receptor, both CPA- and RU486-bound AR recruited Pol II and coactivators p300 and glucocorticoid receptor-interacting protein 1 (GRIP1) onto the promoter and enhancer. However, CPA and RU486 also brought about a simultaneous recruitment of the nuclear receptor corepressor (NCOR) onto the promoter as efficiently as CDX. There were dynamic changes in covalent modifications of histone H3: acetylation of lysine 9 and 14, methylation of arginine 17, phosphorylation of serine 10 as well as di- and tri-methylation at lysine 4 of the H3 N-terminal tail were enhanced in response to T, but not after CDX treatment. Collectively, these results indicate that transcriptional activation by AR is accompanied by a cascade of distinct covalent histone modifications and that the pure antiandrogen CDX and the partial antagonists CPA and RU486 exhibit clear differences in their ability to promote recruitment of histone-acetylating and histone-deacetylating complexes in human prostate cancer cells.
Similar articles
-
The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.Mol Endocrinol. 2006 May;20(5):1048-60. doi: 10.1210/me.2005-0324. Epub 2005 Dec 22. Mol Endocrinol. 2006. PMID: 16373395
-
Expression and function of androgen receptor coactivators in prostate cancer.J Steroid Biochem Mol Biol. 2004 Nov;92(4):265-71. doi: 10.1016/j.jsbmb.2004.10.003. Epub 2004 Dec 19. J Steroid Biochem Mol Biol. 2004. PMID: 15663989 Review.
-
Nuclear receptor recruitment of histone-modifying enzymes to target gene promoters.Vitam Horm. 2004;68:93-122. doi: 10.1016/S0083-6729(04)68003-4. Vitam Horm. 2004. PMID: 15193452 Review.
-
Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).Biochem J. 2004 May 1;379(Pt 3):731-8. doi: 10.1042/BJ20031456. Biochem J. 2004. PMID: 14744261 Free PMC article.
-
Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.J Biol Chem. 2002 Dec 13;277(50):48366-71. doi: 10.1074/jbc.M209074200. Epub 2002 Oct 9. J Biol Chem. 2002. PMID: 12376534
Cited by
-
Association of PSA variability with prostate cancer development using large-scale medical information data: a retrospective cohort study.Genes Environ. 2023 Oct 17;45(1):25. doi: 10.1186/s41021-023-00280-7. Genes Environ. 2023. PMID: 37848957 Free PMC article.
-
The epigenetic function of androgen receptor in prostate cancer progression.Front Cell Dev Biol. 2023 Mar 21;11:1083486. doi: 10.3389/fcell.2023.1083486. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37025180 Free PMC article. Review.
-
Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression.Nat Commun. 2021 Sep 7;12(1):5325. doi: 10.1038/s41467-021-25623-2. Nat Commun. 2021. PMID: 34493733 Free PMC article.
-
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.Cancers (Basel). 2021 Jul 2;13(13):3325. doi: 10.3390/cancers13133325. Cancers (Basel). 2021. PMID: 34283056 Free PMC article. Review.
-
Identification of transcription factor co-regulators that drive prostate cancer progression.Sci Rep. 2020 Nov 23;10(1):20332. doi: 10.1038/s41598-020-77055-5. Sci Rep. 2020. PMID: 33230156 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous